{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:43:58Z","timestamp":1792143838556,"version":"4.4.0"},"reference-count":112,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T00:00:00Z","timestamp":1702252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Extensive genome-wide sequencing efforts have unveiled the intricate regulatory potential of long non-protein coding RNAs (lncRNAs) within the domain of haematological malignancies. Notably, lncRNAs have been found to directly modulate chromatin architecture, thereby impacting gene expression and disease progression by interacting with DNA, RNA, and proteins in a tissue- or condition-specific manner. Furthermore, recent studies have highlighted the intricate epigenetic control of lncRNAs in cancer. Consequently, this provides a rationale to explore the possibility of therapeutically targeting lncRNAs themselves or the epigenetic mechanisms that govern their activity. Within the scope of this review, we will assess the current state of knowledge regarding the epigenetic regulation of lncRNAs and how, in turn, lncRNAs contribute to chromatin remodelling in the context of multiple myeloma.<\/jats:p>","DOI":"10.3389\/fonc.2023.1303677","type":"journal-article","created":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T05:44:47Z","timestamp":1702273487000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["The complex nature of lncRNA-mediated chromatin dynamics in multiple myeloma"],"prefix":"10.3389","volume":"13","author":[{"given":"Patrick","family":"Nylund","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berta","family":"Garrido-Zabala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Kalushkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena Jernberg","family":"Wiklund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,12,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/nyas.13038","article-title":"Multiple myeloma in the marrow: pathogenesis and treatments","volume":"1364","author":"Fairfield","year":"2016","journal-title":"Ann N Y Acad Sci"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2016.11.004","article-title":"Multiple myeloma epidemiology and survival: A unique Malignancy","volume":"43","author":"Kazandjian","year":"2016","journal-title":"Semin Oncol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2017.09.007","article-title":"Epigenetics in multiple myeloma: From mechanisms to therapy","volume":"51","author":"Alzrigat","year":"2018","journal-title":"Semin Cancer Biol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3257","article-title":"The genetic architecture of multiple myeloma","volume":"12","author":"Morgan","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-09-825331","article-title":"Toward personalized treatment in multiple myeloma based on molecular characteristics","volume":"133","author":"Pawlyn","year":"2019","journal-title":"Blood."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2023.282965","article-title":"PVT1 interacts with polycomb repressive complex 2 to suppress genomic regions with pro-apoptotic and tumour suppressor functions in multiple myeloma","author":"Nylund","year":"2023","journal-title":"Haematologica"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0011483","article-title":"Polycomb target genes are silenced in multiple myeloma","volume":"5","author":"Kalushkova","year":"2010","journal-title":"PloS One"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.6843","article-title":"Genome-wide profiling of histone H3 lysine 27 and lysine 4 trimethylation in multiple myeloma reveals the importance of Polycomb gene targeting and highlights EZH2 as a potential therapeutic target","volume":"7","author":"Agarwal","year":"2016","journal-title":"Oncotarget."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.14378","article-title":"EZH2 inhibition in multiple myeloma downregulates myeloma associated oncogenes and upregulates microRNAs with potential tumor suppressor functions","volume":"8","author":"Alzrigat","year":"2017","journal-title":"Oncotarget."},{"key":"B10","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/s41419-021-03447-8","article-title":"A distinct metabolic response characterizes sensitivity to EZH2 inhibition in multiple myeloma","volume":"12","author":"Nylund","year":"2021","journal-title":"Cell Death Dis"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-04-279539","article-title":"Aberrant global methylation patterns affect the molecular pathogenesis and prognosis of multiple myeloma","volume":"117","author":"Walker","year":"2011","journal-title":"Blood."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1101\/gr.180240.114","article-title":"Whole-epigenome analysis in multiple myeloma reveals DNA hypermethylation of B cell-specific enhancers","volume":"25","author":"Agirre","year":"2015","journal-title":"Genome Res"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.7150\/thno.54453","article-title":"Comprehensive characterization of the epigenetic landscape in multiple Myeloma","volume":"12","author":"Alaterre","year":"2022","journal-title":"Theranostics"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1101\/gr.265520.120","article-title":"Chromatin activation as a unifying principle underlying pathogenic mechanisms in multiple myeloma","volume":"30","author":"Ordo\u00f1ez","year":"2020","journal-title":"Genome Res"},{"key":"B15","doi-asserted-by":"publisher","first-page":"106967","DOI":"10.1016\/j.leukres.2022.106967","article-title":"LncRNA MEG3 promotes the sensitivity of bortezomib by inhibiting autophagy in multiple myeloma","volume":"123","author":"Zang","year":"2022","journal-title":"Leuk Res"},{"key":"B16","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/s41419-018-1219-0","article-title":"LncRNA H19 overexpression induces bortezomib resistance in multiple myeloma by targeting MCL-1 via miR-29b-3p","volume":"10","author":"Pan","year":"2019","journal-title":"Cell Death Dis"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2164449","DOI":"10.1080\/16078454.2022.2164449","article-title":"Identification of long noncoding RNA NEAT1 as a key gene involved in the extramedullary disease of multiple myeloma by bioinformatics analysis","volume":"28","author":"Chen","year":"2023","journal-title":"Hematology."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3727\/096504017X15123872205507","article-title":"Aberrant lncRNA expression in multiple myeloma","volume":"26","author":"Meng","year":"2018","journal-title":"Oncol Res"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-021-01147-y","article-title":"Characterization of complete lncRNAs transcriptome reveals the functional and clinical impact of lncRNAs in multiple myeloma","volume":"35","author":"Carrasco-Leon","year":"2021","journal-title":"Leukemia."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1101\/gr.131037.111","article-title":"Genome-wide analysis of long noncoding RNA stability","volume":"22","author":"Clark","year":"2012","journal-title":"Genome Res"},{"key":"B21","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13059-015-0586-4","article-title":"Localization and abundance analysis of human lncRNAs at single-cell and single-molecule resolution","volume":"16","author":"Cabili","year":"2015","journal-title":"Genome Biol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3390\/ncrna5010013","article-title":"Long non-coding RNAs in multiple myeloma","volume":"5","author":"Butova","year":"2019","journal-title":"Noncoding RNA"},{"key":"B23","doi-asserted-by":"publisher","first-page":"152604","DOI":"10.1016\/j.prp.2019.152604","article-title":"Long noncoding RNA PANDA promotes esophageal squamous carcinoma cell progress by dissociating from NF-YA but interact with SAFA","volume":"215","author":"Shi","year":"2019","journal-title":"Pathol Res Pract"},{"key":"B24","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.biomaterials.2014.12.023","article-title":"Suppression of hepatocellular carcinoma by baculovirus-mediated expression of long non-coding RNA PTENP1 and MicroRNA regulation","volume":"44","author":"Chen","year":"2015","journal-title":"Biomaterials."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13081976","article-title":"The role of lncRNAs in the pathobiology and clinical behavior of multiple myeloma","volume":"13","author":"Carrasco-Leon","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/nrg.2016.169","article-title":"Detecting RNA modifications in the epitranscriptome: predict and validate","volume":"18","author":"Helm","year":"2017","journal-title":"Nat Rev Genet"},{"key":"B27","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.molcel.2014.09.001","article-title":"Dynamic RNA modifications in posttranscriptional regulation","volume":"56","author":"Wang","year":"2014","journal-title":"Mol Cell"},{"key":"B28","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12943-020-01159-9","article-title":"Epigenetic modulations of noncoding RNA: a novel dimension of Cancer biology","volume":"19","author":"Yang","year":"2020","journal-title":"Mol Cancer"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/nature11112","article-title":"Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq","volume":"485","author":"Dominissini","year":"2012","journal-title":"Nature."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2012.05.003","article-title":"Comprehensive analysis of mRNA methylation reveals enrichment in 3' UTRs and near stop codons","volume":"149","author":"Meyer","year":"2012","journal-title":"Cell."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2017.55","article-title":"5-methylcytosine promotes mRNA export - NSUN2 as the methyltransferase and ALYREF as an m(5)C reader","volume":"27","author":"Yang","year":"2017","journal-title":"Cell Res"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkz736","article-title":"Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing","volume":"47","author":"Enroth","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1080\/15476286.2020.1722449","article-title":"RNA modifications and cancer","volume":"17","author":"Haruehanroengra","year":"2020","journal-title":"RNA Biol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/nature16998","article-title":"The dynamic N(1)-methyladenosine methylome in eukaryotic messenger RNA","volume":"530","author":"Dominissini","year":"2016","journal-title":"Nature."},{"key":"B35","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1186\/1471-2407-14-809","article-title":"MALAT1 long non-coding RNA is overexpressed in multiple myeloma and may serve as a marker to predict disease progression","volume":"14","author":"Cho","year":"2014","journal-title":"BMC Cancer"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3727\/096504017X14886679715637","article-title":"Long noncoding RNA CRNDE promotes multiple myeloma cell growth by suppressing miR-451","volume":"25","author":"Meng","year":"2017","journal-title":"Oncol Res"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1038\/s41467-020-14337-6","article-title":"RADICL-seq identifies general and cell type-specific principles of genome-wide RNA-chromatin interactions","volume":"11","author":"Bonetti","year":"2020","journal-title":"Nat Commun"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.27024","article-title":"Chromatin-associated RNA sequencing (ChAR-seq) maps genome-wide RNA-to-DNA contacts","volume":"7","author":"Bell","year":"2018","journal-title":"Elife"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/s41592-019-0407-x","article-title":"HiChIRP reveals RNA-associated chromosome conformation","volume":"16","author":"Mumbach","year":"2019","journal-title":"Nat Methods"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14092048","article-title":"DNA methylation regulates a set of long non-coding RNAs compromising hepatic identity during hepatocarcinogenesis","volume":"14","author":"Recalde","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/nrg3354","article-title":"DNA methylation: roles in mammalian development","volume":"14","author":"Smith","year":"2013","journal-title":"Nat Rev Genet"},{"key":"B42","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/B978-0-12-380866-0.60002-2","article-title":"DNA methylation and cancer","volume":"70","author":"Kulis","year":"2010","journal-title":"Adv Genet"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3390\/epigenomes5040022","article-title":"One omics approach does not rule them all: the metabolome and the epigenome join forces in haematological Malignancies","volume":"5","author":"Kalushkova","year":"2021","journal-title":"Epigenomes."},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-19-0400","article-title":"Identification of coding and long noncoding RNAs differentially expressed in tumors and preferentially expressed in healthy tissues","volume":"79","author":"Unfried","year":"2019","journal-title":"Cancer Res"},{"key":"B45","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1186\/s12935-020-01504-4","article-title":"Epigenetic silencing of long non-coding RNA BM742401 in multiple myeloma: impact on prognosis and myeloma dissemination","volume":"20","author":"Li","year":"2020","journal-title":"Cancer Cell Int"},{"key":"B46","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s12943-015-0444-8","article-title":"Epigenetic silencing of a long non-coding RNA KIAA0495 in multiple myeloma","volume":"14","author":"Wong","year":"2015","journal-title":"Mol Cancer"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.4149\/neo_2021_210205N184","article-title":"LncRNA ANRIL promotes multiple myeloma progression and bortezomib resistance by EZH2-mediated epigenetically silencing of PTEN","volume":"68","author":"Yang","year":"2021","journal-title":"Neoplasma."},{"key":"B48","doi-asserted-by":"publisher","first-page":"110058","DOI":"10.1016\/j.intimp.2023.110058","article-title":"Abnormal expression pattern of lncRNA H19 participates in multiple myeloma bone disease by unbalancing osteogenesis and osteolysis","volume":"119","author":"Guo","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-01034-y","article-title":"The long non-coding RNA CRNDE regulates growth of multiple myeloma cells via an effect on IL6 signalling","volume":"35","author":"David","year":"2021","journal-title":"Leukemia."},{"key":"B50","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/s41419-019-1551-z","article-title":"Bortezomib-inducible long non-coding RNA myocardial infarction associated transcript is an oncogene in multiple myeloma that suppresses miR-29b","volume":"10","author":"Fu","year":"2019","journal-title":"Cell Death Dis"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2019.10603","article-title":"Increased lncRNA HOTAIR expression promotes the chemoresistance of multiple myeloma to dexamethasone by regulating cell viability and apoptosis by mediating the JAK2\/STAT3 signaling pathway","volume":"20","author":"Guan","year":"2019","journal-title":"Mol Med Rep"},{"key":"B52","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1182\/blood.2022016892","article-title":"A MIR17HG-derived long noncoding RNA provides an essential chromatin scaffold for protein interaction and myeloma growth","volume":"141","author":"Morelli","year":"2023","journal-title":"Blood."},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1126\/science.1163802","article-title":"The Air noncoding RNA epigenetically silences transcription by targeting G9a to chromatin","volume":"322","author":"Nagano","year":"2008","journal-title":"Science."},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.29573","article-title":"LncRNA HOXB-AS1 promotes cell growth in multiple myeloma via FUT4 mRNA stability by ELAVL1","volume":"121","author":"Chen","year":"2020","journal-title":"J Cell Biochem"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.218289","article-title":"Hypoxia-induced long non-coding RNA DARS-AS1 regulates RBM39 stability to promote myeloma Malignancy","volume":"105","author":"Tong","year":"2020","journal-title":"Haematologica."},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-018-0104-2","article-title":"Targeting the MALAT1\/PARP1\/LIG3 complex induces DNA damage and apoptosis in multiple myeloma","volume":"32","author":"Hu","year":"2018","journal-title":"Leukemia."},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1080\/15384101.2019.1652034","article-title":"LncRNA MALAT1\/miR-181a-5p affects the proliferation and adhesion of myeloma cells via regulation of Hippo-YAP signaling pathway","volume":"18","author":"Sun","year":"2019","journal-title":"Cell Cycle"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-019-0542-5","article-title":"Long non-coding RNA NEAT1 targeting impairs the DNA repair machinery and triggers anti-tumor activity in multiple myeloma","volume":"34","author":"Taiana","year":"2020","journal-title":"Leukemia."},{"key":"B59","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/leu.2011.344","article-title":"Epigenetic regulation of miRNA genes in acute leukemia","volume":"26","author":"Agirre","year":"2012","journal-title":"Leukemia."},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2012.06.005","article-title":"miRNAs and cancer: an epigenetics view","volume":"34","author":"Malumbres","year":"2013","journal-title":"Mol Aspects Med"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23105801","article-title":"Histone modifications and non-coding RNAs: mutual epigenetic regulation and role in pathogenesis","volume":"23","author":"Bure","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2011.22","article-title":"Regulation of chromatin by histone modifications","volume":"21","author":"Bannister","year":"2011","journal-title":"Cell Res"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.00382-19","article-title":"Long noncoding RNA H19 promotes tumorigenesis of multiple myeloma by activating BRD4 signaling by targeting microRNA 152-3p","volume":"40","author":"Zheng","year":"2020","journal-title":"Mol Cell Biol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2012.12.006","article-title":"Phospho switch triggers Brd4 chromatin binding and activator recruitment for gene-specific targeting","volume":"49","author":"Wu","year":"2013","journal-title":"Mol Cell"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111.323493","article-title":"Bromodomain protein Brd4 associated with acetylated chromatin is important for maintenance of higher-order chromatin structure","volume":"287","author":"Wang","year":"2012","journal-title":"J Biol Chem"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-0098","article-title":"The novel bromodomain and extraterminal domain inhibitor INCB054329 induces vulnerabilities in myeloma cells that inform rational combination strategies","volume":"25","author":"Stubbs","year":"2019","journal-title":"Clin Cancer Res"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.328","article-title":"Long noncoding RNA CRNDE promotes colorectal cancer cell proliferation via epigenetically silencing DUSP5\/CDKN1A expression","volume":"8","author":"Ding","year":"2017","journal-title":"Cell Death Dis"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.21465","article-title":"Long noncoding RNA MIAT promotes non-small cell lung cancer proliferation and metastasis through MMP9 activation","volume":"8","author":"Lai","year":"2017","journal-title":"Oncotarget."},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1126\/science.1192002","article-title":"Long noncoding RNA as modular scaffold of histone modification complexes","volume":"329","author":"Tsai","year":"2010","journal-title":"Science."},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aao2110","article-title":"How do lncRNAs regulate transcription","volume":"3","author":"Long","year":"2017","journal-title":"Sci Adv"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1080\/15476286.2022.2079889","article-title":"DARS-AS1 recruits METTL3\/METTL14 to bind and enhance DARS mRNA m(6)A modification and\u00a0translation for cytoprotective autophagy in cervical cancer","volume":"19","author":"Shen","year":"2022","journal-title":"RNA Biol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"ra8","DOI":"10.1126\/scisignal.2000568","article-title":"Noncoding RNA gas5 is a growth arrest- and starvation-associated repressor of the glucocorticoid receptor","volume":"3","author":"Kino","year":"2010","journal-title":"Sci Signal"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.16551","article-title":"MALAT1 predicts poor survival in osteosarcoma patients and promotes cell metastasis through associating with EZH2","volume":"8","author":"Huo","year":"2017","journal-title":"Oncotarget."},{"key":"B74","doi-asserted-by":"publisher","first-page":"110265","DOI":"10.1016\/j.cellsig.2022.110265","article-title":"NCAPD3 promotes prostate cancer progression by up-regulating EZH2 and MALAT1 through STAT3 and E2F1","volume":"92","author":"Jing","year":"2022","journal-title":"Cell Signal"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.5728","article-title":"LncRNA MALAT1 enhances oncogenic activities of EZH2 in castration-resistant prostate cancer","volume":"6","author":"Wang","year":"2015","journal-title":"Oncotarget."},{"key":"B76","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1038\/s41419-020-03164-8","article-title":"LncRNA NEAT1 remodels chromatin to promote the 5-Fu resistance by maintaining colorectal cancer stemness","volume":"11","author":"Zhu","year":"2020","journal-title":"Cell Death Dis"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2020.00250","article-title":"LncRNA NEAT1 Interacted With DNMT1 to Regulate Malignant Phenotype of Cancer Cell and Cytotoxic T Cell Infiltration via Epigenetic Inhibition of p53, cGAS, and STING in Lung Cancer","volume":"11","author":"Ma","year":"2020","journal-title":"Front Genet"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.3390\/genes10010052","article-title":"Epitranscriptomic signatures in lncRNAs and their possible roles in cancer","volume":"10","author":"Dinescu","year":"2019","journal-title":"Genes (Basel)"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1063636","article-title":"The lncRNA epigenetics: The significance of m6A and m5C lncRNA modifications in cancer","volume":"13","author":"Cusenza","year":"2023","journal-title":"Front Oncol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-020-0253-2","article-title":"Role of RNA modifications in cancer","volume":"20","author":"Barbieri","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1038\/nature19342","article-title":"m(6)A RNA methylation promotes XIST-mediated transcriptional repression","volume":"537","author":"Patil","year":"2016","journal-title":"Nature."},{"key":"B82","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12943-019-1014-2","article-title":"m(6)A-induced lncRNA RP11 triggers the dissemination of colorectal cancer cells via upregulation of Zeb1","volume":"18","author":"Wu","year":"2019","journal-title":"Mol Cancer"},{"key":"B83","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s12943-019-1079-y","article-title":"Long noncoding RNA GAS5 inhibits progression of colorectal cancer by interacting with and triggering YAP phosphorylation and degradation and is negatively regulated by the m(6)A reader YTHDF3","volume":"18","author":"Ni","year":"2019","journal-title":"Mol Cancer"},{"key":"B84","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.gendis.2020.03.005","article-title":"The functions of N6-methyladenosine modification in lncRNAs","volume":"7","author":"He","year":"2020","journal-title":"Genes Dis"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S181058","article-title":"miR-600 inhibits lung cancer via downregulating the expression of METTL3","volume":"11","author":"Wei","year":"2019","journal-title":"Cancer Manag Res"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2016.11.077","article-title":"MiR-33a suppresses proliferation of NSCLC cells via targeting METTL3 mRNA","volume":"482","author":"Du","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M116.749689","article-title":"MicroRNA-145 modulates N(6)-methyladenosine levels by targeting the 3'-untranslated mRNA region of the N(6)-methyladenosine binding YTH domain family 2 protein","volume":"292","author":"Yang","year":"2017","journal-title":"J Biol Chem"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1002\/hon.3157","article-title":"LncRNA FEZF1-AS1 accelerates multiple myeloma progression by regulating IGF2BP1\/BZW2 signaling","author":"Long","year":"2023","journal-title":"Hematol Oncol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1007\/s10565-021-09690-1","article-title":"METTL3 facilitates multiple myeloma tumorigenesis by enhancing YY1 stability and pri-microRNA-27 maturation in m(6)A-dependent manner","volume":"39","author":"Che","year":"2022","journal-title":"Cell Biol Toxicol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-023-05283-6","article-title":"m6A methyltransferase METTL3 facilitates multiple myeloma cell growth through the m6A modification of BZW2","volume":"102","author":"Huang","year":"2023","journal-title":"Ann Hematol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2021.12.012","article-title":"FTO promotes multiple myeloma progression by posttranscriptional activation of HSF1 in an m(6)A-YTHDF2-dependent manner","volume":"30","author":"Xu","year":"2022","journal-title":"Mol Ther"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1038\/s41417-022-00429-6","article-title":"FTO promotes Bortezomib resistance via m6A-dependent destabilization of SOD2 expression in multiple myeloma","volume":"30","author":"Wang","year":"2023","journal-title":"Cancer Gene Ther"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-021-02095-8","article-title":"RNA demethylase ALKBH5 promotes tumorigenesis in multiple myeloma via TRAF1-mediated activation of NF-kappaB and MAPK signaling pathways","volume":"41","author":"Qu","year":"2022","journal-title":"Oncogene."},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.64943","article-title":"ALKBH5 Promotes Multiple Myeloma Tumorigenicity through inducing m(6)A-demethylation of SAV1 mRNA and Myeloma Stem Cell Phenotype","volume":"18","author":"Yu","year":"2022","journal-title":"Int J Biol Sci"},{"key":"B95","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.molcel.2012.10.015","article-title":"ALKBH5 is a mammalian RNA demethylase that impacts RNA metabolism and mouse fertility","volume":"49","author":"Zheng","year":"2013","journal-title":"Mol Cell"},{"key":"B96","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13046-021-02209-w","article-title":"Induction of m(6)A methylation in adipocyte exosomal LncRNAs mediates myeloma drug resistance","volume":"41","author":"Wang","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"key":"B97","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s12943-020-01293-4","article-title":"Long non-coding RNA NEAT1 promotes bone metastasis of prostate cancer through N6-methyladenosine","volume":"19","author":"Wen","year":"2020","journal-title":"Mol Cancer"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.5135","article-title":"Aberrantly expressed long noncoding RNAs as potential prognostic biomarkers in newly diagnosed multiple myeloma: A systemic review and meta-analysis","volume":"12","author":"Qin","year":"2023","journal-title":"Cancer Med"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2022.281167","article-title":"Activation of long non-coding RNA NEAT1 leads to survival advantage of multiple myeloma cells by supporting a positive regulatory loop with DNA repair proteins","volume":"108","author":"Taiana","year":"2023","journal-title":"Haematologica."},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.22008","article-title":"LncRNA NEAT1 promotes dexamethasone resistance in multiple myeloma by targeting miR-193a\/MCL1 pathway","volume":"32","author":"Wu","year":"2018","journal-title":"J Biochem Mol Toxicol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1002\/wrna.1639","article-title":"Dynamic transcriptomic m(5) C and its regulatory role in RNA processing","volume":"12","author":"Chen","year":"2021","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.920164","article-title":"m(5)C Regulator-mediated methylation modification clusters contribute to the immune microenvironment regulation of multiple myeloma","volume":"13","author":"Ren","year":"2022","journal-title":"Front Genet"},{"key":"B103","doi-asserted-by":"publisher","first-page":"7467797","DOI":"10.1155\/2022\/7467797","article-title":"Signature of m5C-Related lncRNA for Prognostic Prediction and Immune Responses in Pancreatic Cancer","volume":"2022","author":"Liu","year":"2022","journal-title":"J\u00a0Oncol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.671821","article-title":"m5C-related lncRNAs predict overall survival of patients and regulate the tumor immune microenvironment in lung adenocarcinoma","volume":"9","author":"Pan","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.885568","article-title":"M5C-related lncRNA predicts lung adenocarcinoma and tumor microenvironment remodeling: computational biology and basic science","volume":"10","author":"Bai","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1038\/nature24456","article-title":"The m1A landscape on cytosolic and mitochondrial mRNA at single-base resolution","volume":"551","author":"Safra","year":"2017","journal-title":"Nature."},{"key":"B107","doi-asserted-by":"publisher","first-page":"188502","DOI":"10.1016\/j.bbcan.2021.188502","article-title":"Diagnostic, prognostic, and therapeutic significance of long non-coding RNA MALAT1 in cancer","volume":"1875","author":"Goyal","year":"2021","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-020-03127-8","article-title":"Long non-coding RNA MALAT1 facilitates the tumorigenesis, invasion and glycolysis of multiple myeloma via miR-1271-5p\/SOX13 axis","volume":"146","author":"Liu","year":"2020","journal-title":"J Cancer Res Clin Oncol"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.21957","article-title":"LncRNA MALAT1 acts as an oncogene in multiple myeloma through sponging miR-509-5p to modulate FOXP1 expression","volume":"8","author":"Gu","year":"2017","journal-title":"Oncotarget."},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcb.2022.07.001","article-title":"Role of N7-methylguanosine (m(7)G) in cancer","volume":"32","author":"Chen","year":"2022","journal-title":"Trends Cell Biol"},{"key":"B111","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1186\/s12864-023-09526-8","article-title":"Landscape of internal N7-methylguanosine of long non-coding RNA modifications in resistant acute myeloid leukemia","volume":"24","author":"Han","year":"2023","journal-title":"BMC Genomics"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.934928","article-title":"A novel m7G-related lncRNA risk model for predicting prognosis and evaluating the tumor immune microenvironment in colon carcinoma","volume":"12","author":"Yang","year":"2022","journal-title":"Front Oncol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1303677\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T05:44:50Z","timestamp":1702273490000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1303677\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,11]]},"references-count":112,"alternative-id":["10.3389\/fonc.2023.1303677"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2023.1303677","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,11]]},"article-number":"1303677"}}